# Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

> **NCT00413699** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 4488 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** CP-690,550
- **DRUG:** CP-690,550

## Key facts

- **NCT ID:** NCT00413699
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-05
- **Primary completion:** 2016-11-30
- **Final completion:** 2017-10-26
- **Target enrollment:** 4488 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413699, "Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00413699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*